UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2012, ISBN 9789004215986, xxxix, 515
Book
Biological reviews of the Cambridge Philosophical Society, ISSN 1464-7931, 05/2012, Volume 87, Issue 2, pp. 290 - 312
modelling | marine | settlement | vertebrates | trade‐offs | transfer | terrestrial | fitness | global change | plants | departure | micro‐organisms | aquatic | invertebrates | movement | Movement | Plants | Micro-organisms | Settlement | Vertebrates | Marine | Aquatic | Departure | Trade-offs | Global change | Transfer | Terrestrial | Modelling | Invertebrates | Fitness | Biology | Life Sciences & Biomedicine - Other Topics | Life Sciences & Biomedicine | Science & Technology | Biological Evolution | Animals | Demography | Models, Biological | Ecosystem | Gene flow | Energy transfer (Ecology) | Research | Dispersal (Ecology) | Organisms | Simulation | Dispersal | Conservation | Nonnative species | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1217 - 1227
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Atherosclerosis - drug therapy | Double-Blind Method | Cholesterol - blood | Humans | Middle Aged | Kaplan-Meier Estimate | Atherosclerosis - complications | Coronary Disease - epidemiology | Male | Oxazolidinones - adverse effects | Anticholesteremic Agents - adverse effects | Coronary Disease - mortality | Incidence | Oxazolidinones - therapeutic use | Coronary Disease - prevention & control | Medication Adherence | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Female | Aged | Drug Therapy, Combination | Myocardial infarction | Lipoproteins (low density) | Inhibitor drugs | Heart attacks | Clinical trials | Lipids | Low density lipoprotein | Cholesterol | Cholesteryl ester transfer protein | Clinical outcomes | Side effects | Arteriosclerosis | Atherosclerosis | Atorvastatin | Cardiovascular diseases | Health risk assessment | Drug therapy | Lipoproteins (high density) | Cancer | Index Medicus | Abridged Index Medicus
Journal Article